<div id="readability-page-1">WALTHAM, Mass., April 21, 2025 — In a recent development, Aerovate Therapeutics, Inc. (Nasdaq: AVTE) has shared that its Board of Directors has given the green light to a 1-for-35 reverse stock split. Following this decision, the stockholders have also voted in favor of the proposed merger with Jade Biosciences, Inc. This move marks a significant milestone for the company as it looks to bolster its position in the market.</div>

AVTE

<p>WALTHAM, Mass., April 21, 2025 — In a recent development, Aerovate Therapeutics, Inc. (Nasdaq: AVTE) has shared that its Board of Directors has given the green light to a 1-for-35 reverse stock split. Following this decision, the stockholders have also voted in favor of the proposed merger with Jade Biosciences, Inc. This move marks a significant milestone for the company as it looks to bolster its position in the market.</p>

Aerovate's stockholders approve merger with Jade Biosciences and 1-for-35 reverse stock split.